Company page

Bavarian Nordic A/s

Bavarian Nordic A/S is a public company listed on the Danish market under the ticker BAVA. The company has a market capitalization of approximately 2.12 billion USD. Bavarian Nordic focuses on developing and manufacturing innovative vaccines and immunotherapies.

BAVA:OMXCOPUpdated August 22, 2026
Bavarian Nordic A/s logo
Ticker
BAVA:OMXCOP
Asset type
Stock
Market cap
$2.37B
Sector
Health Technology
Industry
Biotechnology
Exchange
OMXCOP
Currency
DKK